Recent Advancement of Colorectal Cancer and Their Herbal Essential Oil Treatment

Aditya Kumar; Yashika Uniyal; Roshan Kumar

doi:10.55544/jrasb.1.5.15

Authors

Aditya Kumar Research Scholar, Department of Pharmacy, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.
Mrs. Yashika Uniyal Assistant Professor, Department of Pharmacology, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.
Roshan Kumar Assistant Professor, Department of Pharmacology, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.

DOI:

https://doi.org/10.55544/jrasb.1.5.15

Keywords:

Colorectal, Cancer, Chemical therapy, Herbal treatment

Abstract

Colorectal cancer is the second most deadly type of cancer (CRC). In the upcoming decades, death and incidence rates would surely increase globally. Despite being disproportionately high in high-income countries, CRC-related mortality is also on the rise in low- and middle-income countries. Early diagnosis of CRC allows for both surgical and medicinal treatment options. Due to the high likelihood of recurrence and the rising rate of treatment failure brought on by cancer medicine resistance, it is regrettable that there is a significant treatment failure rate. Due to early discovery and treatment of CRC, there is a chance of survival in wealthy nations. Contrarily, these resources are noticeably scarce in less developed countries. It is crucial to inform the public about CRC's current situation, its cause, progression, risk factors, and therapy. As a result, we have included in this review all of the most recent data on the global epidemiology, drug resistance, challenges, risk factors, and preventative and therapeutic approaches for CRC. Guidelines for CRC prevention and therapy are briefly reviewed, as well as pathways of CRC developments.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., Goh, K. W., & Hadi, M. A. (2022). Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers, 14(7), 1732. https://doi.org/10.3390/cancers14071732

WHO Cancer. [(accessed on 14 July 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer

Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. [(accessed on 14 July 2021)]. Available online: https://gco.iarc.fr/today

Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull. Environ. Pharmacol. Life Sci, 9, 149-155.

Papamichael D., Audisio R.A., Glimelius B., de Gramont A., Glynne-Jones R., Haller D., Kohne C.H., Rostoft S., Lemmens V., Mitry E., et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2015;26:463–476. doi: 10.1093/annonc/mdu253.

Triantafillidis J.K., Nasioulas G., Kosmidis P.A. Colorectal cancer and inflammatory bowel disease: Epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29:2727–2737.

Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., Jemal A., Schymura M.J., Lansdorp-Vogelaar I., Seeff L.C., et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573. doi: 10.1002/cncr.24760.

Umama, Y., Venkatajah, G., Shourabh, R., Kumar, R., Verma, A., Kumar, A., & Gayoor, M. K. (2019). Topic-The scenario of pharmaceuticals and development of microwave as; sisted extraction technique. World J Pharm Pharm Sci, 8(7), 1260-1271.

Navarro M., Nicolas A., Ferrandez A., Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J. Gastroenterol. 2017;23:3632–3642. doi: 10.3748/wjg.v23.i20.3632.

Wilson J.M., Jungner Y.G. Principles and practice of mass screening for disease. Bol. Oficina Sanit. Panam. 1968;65:281–393.

Morson B.C. The evolution of colorectal carcinoma. Clin. Radiol. 1984;35:425–431. doi: 10.1016/S0009-9260(84)80033-1.

Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. Natural Bioactives For The Potential Management Of Gastric Ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3)

Winawer S.J., Fletcher R.H., Miller L., Godlee F., Stolar M.H., Mulrow C.D., Woolf S.H., Glick S.N., Ganiats T.G., Bond J.H., et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology. 1997;112:594–642. doi: 10.1053/gast.1997.v112.agast970594.

Roshan, K. (2020). Priya damwani, Shivam kumar, Adarsh suman, Suthar Usha. An overview on health benefits and risk factor associated with coffee. International Journal Research and Analytical Review, 7(2), 237-249.

Winawer S.J., Zauber A.G., Ho M.N., O’Brien M.J., Gottlieb L.S., Sternberg S.S., Waye J.D., Schapiro M., Bond J.H., Panish J.F., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993;329:1977–1981. doi: 10.1056/NEJM199312303292701.

Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.

Ciccolallo L., Capocaccia R., Coleman M.P., Berrino F., Coebergh J.W.W., Damhuis R.A.M., Faivre J., Martinez-Garcia C., Møller H., De Leon M.P. Survival differences between European and US patients with colorectal cancer: Role of stage at diagnosis and surgery. Gut. 2005;54:268–273. doi: 10.1136/gut.2004.044214.

Garcia-Etxebarria K., Clos-Garcia M., Telleria O., Nafría B., Alonso C., Iruarrizaga-Lejarreta M., Franke A., Crespo A., Iglesias A., Cubiella J., et al. Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer. Cancers. 2021;13:6216. doi: 10.3390/cancers13246216.

Keum N., Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 2019;16:713–732. doi: 10.1038/s41575-019-0189-8.

Nyarko, R. O., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201.

ACS Cancer Facts & Figures. 2020. [(accessed on 15 July 2021)]. Available online: https://www.cancer.org/cancer/colon-rectal-cancer/

Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330. doi: 10.1038/nature11252.

Testa U., Pelosi E., Castelli G. Colorectal cancer: Genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med. Sci. 2018;6:31. doi: 10.3390/medsci6020031.

Malki A., ElRuz R.A., Gupta I., Allouch A., Vranic S., Al Moustafa A.E. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. Int. J. Mol. Sci. 2020;22:130. doi: 10.3390/ijms22010130.

Saha, P., Kumar, R., Nyarko, R.O., Kahwa, I. and Owusu, P., 2021. HERBAL SECONDARY METABOLITE FOR GASTRO-PROTECTIVE ULCER ACTIVITY WITH API STRUCTURES.

Nguyen H.T., Duong H.Q. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy. Oncol. Lett. 2018;16:9–18. doi: 10.3892/ol.2018.8679.

Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988;319:525–532. doi: 10.1056/NEJM198809013190901.

Sahana S. Roshan kumar, Sourav nag, Reshmi paul, Nilayan guha, Indranil Chatterjee. A Review on Alzheimer disease and future prospects. World Journal of Pharmacy and Pharmaceutical science. 2020;9(9):1276-85.

Pickhardt P.J., Kim D.H., Pooler B.D., Hinshaw J.L., Barlow D., Jensen D., Reichelderfer M., Cash B.D. Volumetric growth rates of small colorectal polyps: Longitudinal investigation of natural history using CT colonography. Lancet Oncol. 2013;14:711. doi: 10.1016/S1470-2045(13)70216-X.

Stryker S.J., Wolff B.G., Culp C.E., Libbe S.D., Ilstrup D.M., MacCarty R.L. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009–1013. doi: 10.1016/0016-5085(87)90563-4.

Nyarko RO, Saha P, Kumar R, Kahwa I, Boateng EA, Boateng PO, Christian A, Bertram A. Role of Cytokines and Vaccines in Break through COVID 19 Infections. Journal of Pharmaceutical Research International. 2021;33(60B):2544-9.

NIH Advances in Colorectal Cancer Research: Stages of Colorectal Cancer. [(accessed on 30 December 2021)]; Available online: https://www.nih.gov/research-training/advances-colorectal-cancer-research

Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A REVIEW ON ALZHEIMER DISEASE AND FUTURE PROSPECTS.

Slattery M.L., Edwards S.L., Samowitz W. Stage of colon cancer at diagnosis: Implications for risk factor associations? Int. J. Epidemiol. 1998;27:382–387. doi: 10.1093/ije/27.3.382.

Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). ANTIBACTERIAL ACTIVITY OF HERBAL PLANT-TINOSPORA CORDIFOLIA AND CATHARNTHUS ROSEUS.

Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660.

GLOBOCAN Global Cancer Observatory (GCO): Cancer Today. [(accessed on 15 August 2021)]. Available online: https://gco.iarc.fr/today/#

Kumar R, Saha P, Kumar Y, Sahana S, Dubey A, Prakash O. A Review on Diabetes Mellitus: Type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences. 2020 Aug 2;9(10):838-50.

Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492.

Smit W.L., Spaan C.N., de Boer R.J., Ramesh P., Garcia T.M., Meijer B.J., Vermeulen J.L.M., Lezzerini M., MacInnes A.W., Koster J., et al. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity. Proc. Natl. Acad. Sci. USA. 2020;117:25560–25570. doi: 10.1073/pnas.1912772117

Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. doi: 10.1016/0092-8674(90)90186-I.

Nyarko RO, Boateng E, Kahwa I, Boateng PO. A comparison analysis on remdesivir, favipiravir, hydroxychloroquine, chloroquine and azithromycin in the treatment of corona virus disease 2019 (COVID-19)-A Review. World J. Pharm. Pharm. Sci. 2020 Mar 8;9:121-33.

Nyarko RO, Boateng E, Kahwa I, Boateng PO, Asare B. The impact on public health and economy using lockdown as a tool against COVID-19 pandemic in Africa: a perspective. J Epidemiol Public Health Rev. 2020;5(3).

Leslie A., Carey F.A., Pratt N.R., Steele R.J. The colorectal adenoma-carcinoma sequence. Br. J. Surg. 2002;89:845–860. doi: 10.1046/j.1365-2168.2002.02120.x.

PDQ PDQ Colon Cancer Treatment. [(accessed on 15 July 2021)]; Available online: https://www.cancer.gov/types/colorectal/hp/colon-treatment-pdq

Safiejko K., Tarkowski R., Koselak M., Juchimiuk M., Tarasik A., Pruc M., Smereka J., Szarpak L. Robotic-Assisted vs. Standard Laparoscopic Surgery for Rectal Cancer Resection: A Systematic Review and Meta-Analysis of 19,731 Patients. Cancers. 2022;14:180. doi: 10.3390/cancers14010180.

Dawson H., Kirsch R., Messenger D., Driman D. A Review of Current Challenges in Colorectal Cancer Reporting. Arch. Pathol. Lab. Med. 2019;143:869–882. doi: 10.5858/arpa.2017-0475-RA.

PURABISAHA RK, RAWAT SS, PRAKASH A. A REVIEW ON NOVEL DRUG DELIVERY SYSTEM.

Dallas N.A., Xia L., Fan F., Gray M.J., Gaur P., van Buren G., 2nd, Samuel S., Kim M.P., Lim S.J., Ellis L.M. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009;69:1951–1957. doi: 10.1158/0008-5472.CAN-08-2023.

Hu T., Li Z., Gao C.Y., Cho C.H. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J. Gastroenterol. 2016;22:6876–6889. doi: 10.3748/wjg.v22.i30.6876.

Kumar R, Saha P, Pathak P, Mukherjee R, Kumar A, Arya RK. EVOLUTION OF TOLBUTAMIDE IN THE TREATMENT OF DIABETES MELLITUS. Jour. of Med. P’ceutical & Alli. Sci.;9.

Driver J.A., Gaziano J.M., Gelber R.P., Lee I.M., Buring J.E., Kurth T. Development of a risk score for colorectal cancer in men. Am. J. Med. 2007;120:257–263. doi: 10.1016/j.amjmed.2006.05.055.

Steele S.R., Park G.E., Johnson E.K., Martin M.J., Stojadinovic A., Maykel J.A., Causey M.W. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Dis. Colon Rectum. 2014;57:303–310. doi: 10.1097/DCR.0b013e3182a586e7.

Daharia A, Jaiswal VK, Royal KP, Sharma H, Joginath AK, Kumar R, Saha P. A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development. 2022 Jun 14;10(3):65-9.

Irby K., Anderson W.F., Henson D.E., Devesa S.S. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975–2002) Cancer Epidemiol. Prev. Biomark. 2006;15:792–797. doi: 10.1158/1055-9965.EPI-05-0879.

Gausman V., Dornblaser D., Anand S., Hayes R.B., O’Connell K., Du M., Liang P.S. Risk Factors Associated With Early-Onset Colorectal Cancer. Clin. Gastroenterol. Hepatol. 2020;18:2752–2759.e2. doi: 10.1016/j.cgh.2019.10.009.

Demb J., Earles A., Martinez M.E., Bustamante R., Bryant A.K., Murphy J.D., Liu L., Gupta S. Risk factors for colorectal cancer significantly vary by anatomic site. BMJ Open Gastroenterol. 2019;6:e000313. doi: 10.1136/bmjgast-2019-000313.

CDC Colorectal Cancer, United States—2007–2016. [(accessed on 13 February 2022)]; Available online: https://www.cdc.gov/cancer/uscs/about/data-briefs/no16-colorectal-cancer-2007-2016.htm

Kumar R, Saha P. A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology. 2022 Jun 25;9(3):149-56.

Ellis L., Abrahao R., McKinley M., Yang J., Somsouk M., Marchand L.L., Cheng I., Gomez S.L., Shariff-Marco S. Colorectal Cancer Incidence Trends by Age, Stage, and Racial/Ethnic Group in California, 1990–2014. Cancer Epidemiol. Prev. Biomark. 2018;27:1011–1018. doi: 10.1158/1055-9965.EPI-18-0030.

Thornton J.G., Morris A.M., Thornton J.D., Flowers C.R., McCashland T.M. Racial variation in colorectal polyp and tumor location. J. Natl. Med. Assoc. 2007;99:723–728.

KUMAR R, SAHA P, SARKAR S, RAWAT N, PRAKASH A. A REVIEW ON NOVEL DRUG DELIVERY SYSTEM. IJRAR-International Journal of Research and Analytical Reviews (IJRAR). 2021 Jan;8(1):183-99.

Peterson Y.C. Risk Factors for Colorectal Cancer. MOJ Surg. 2015;2:37–42. doi: 10.15406/mojs.2015.02.00015.

Johnson C.M., Wei C., Ensor J.E., Smolenski D.J., Amos C.I., Levin B., Berry D.A. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207–1222. doi: 10.1007/s10552-013-0201-5.

Saha P, Nyarko RO, Lokare P, Kahwa I, Boateng PO, Asum C. Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development. 2022 Jun 14;10(3):58-64.

Katsidzira L., Gangaidzo I.T., Makunike-Mutasa R., Manyanga T., Matsena-Zingoni Z., Thomson S., Matenga J.A., Rusakaniko S., Ramesar R. A case–control study of risk factors for colorectal cancer in an African population. Eur. J. Cancer Prev. 2019;28:145. doi: 10.1097/CEJ.0000000000000439.

Kumar R, Jain A, Tripathi AK, Tyagi S. Covid-19 outbreak: An epidemic analysis using time series prediction model. In2021 11th international conference on cloud computing, data science & engineering (Confluence) 2021 Jan 28 (pp. 1090-1094). IEEE.

Avgerinos K.I., Spyrou N., Mantzoros C.S., Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–135. doi: 10.1016/j.metabol.2018.11.001.

KUMAR A. The Scenario of Pharmaceuticals and Development of Microwave Assisted Extraction Techniques.

Moschos S.J., Mantzoros C.S. The role of the IGF system in cancer: From basic to clinical studies and clinical applications. Oncology. 2002;63:317–332. doi: 10.1159/000066230.

Shin A., Joo J., Bak J., Yang H.R., Kim J., Park S., Nam B.H. Site-specific risk factors for colorectal cancer in a Korean population. PLoS ONE. 2011;6:e23196. doi: 10.1371/journal.pone.0023196.

Saha P, Kumar A, Bhanja J, Shaik R, Kawale AL, Kumar R. A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology. 2022 Jun 22;9(3):201-9.

ACS Colorectal Cancer Facts & Figure 2017, Figure 2018 and Figure 2019. [(accessed on 15 September 2021)]. Available online: https://www.cancer.org/content/dam/cancer-org/research/

Nalimu F, Oloro J, Kahwa I, Ogwang PE. Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences. 2021 Dec;7(1):1-21.

Samadder N.J., Jasperson K., Burt R.W. Hereditary and common familial colorectal cancer: Evidence for colorectal screening. Dig. Dis. Sci. 2015;60:734–747. doi: 10.1007/s10620-014-3465-z.

Nyarko RO, Roopini R, Raviteja V, Awuchi CG, Kumar R, Faller EM, Navarro EL, Boateng E, Kahwa I, Boateng PO, Asum C. Novel Sars-CoV-2 Variants & Therapeutic Effects. Journal for Research in Applied Sciences and Biotechnology. 2022 Jun 30;1(2):25-34.

Amle VS, Rathod DA, Keshamma E, Kumar V, Kumar R, Saha P. Bioactive Herbal Medicine Use for Eye Sight: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology. 2022 Aug 31;1(3):42-50.

Subramanian M, Keshamma E, Janjua D, Kumar D, Kumar R, Saha P, Gupta RK, Rao S. Quality Risk Management Approach for Drug Development and Its Future Prospectives. Journal for Research in Applied Sciences and Biotechnology. 2022 Aug 31;1(3):166-77.

Kumar R, Keshamma E, Kumari B, Kumar A, Kumar V, Janjua D, Billah AM. Burn Injury Management, Pathophysiology and Its Future Prospectives. Journal for Research in Applied Sciences and Biotechnology. 2022 Oct 31;1(4):78-89.

Rasool S., Rasool V., Naqvi T., Ganai B.A., Shah B.A. Genetic unraveling of colorectal cancer. Tumor Biol. 2014;35:5067–5082. doi: 10.1007/s13277-014-1713-7.

Chaudhary H, Sagar S, Kumar R, Bisht V, Butola K. Herbal Essential Oil use as Ulcer Protective Activity: A Systematic Review. Journal for Research in Applied Sciences and Biotechnology. 2022 Dec 13;1(5):86-101.

Bugga P, Alam MJ, Kumar R, Pal S, Chattopadyay N, Banerjee SK. Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast. Cellular Signalling. 2022 Jun 1;94:110309.

Singh Y, Paswan SK, Kumar R, Otia MK, Acharya S, Kumar D, E. K. Plant & Its Derivative Shows Therapeutic Activity on Neuroprotective Effect. J. Res. Appl. Sci. Biotechnol. [Internet]. 2022 Jun. 30 [cited 2022 Dec. 20];1(2):10-24. Available from: https://jrasb.com/index.php/jrasb/article/view/7

Pandey M, Singh A, Agnihotri N, Kumar R, Saha P, Pandey RP, Kumar A. Clinical Pharmacology & Therapeutic uses of Diuretic Agents: A Review. Journal for Research in Applied Sciences and Biotechnology. 2022 Aug 31;1(3):11-20.

Kumar R, Saha P, Keshamma E, Sachitanadam P, Subramanian M. Docking Studies of Some Novel Hetrocyclic Compound as Acat Inhibitors: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology. 2022 Aug 31;1(3):33-41.

Keshamma E, Paswan SK, Kumar R, Saha P, Trivedi U, Chourasia A, Otia M. Alkaloid Based Chemical Constituents of Ocimum santum & Cinchona Bark: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology. 2022 Jun 30;1(2):35-42.

Mishra A, Singh Y, Singh R, Kumar R, Shukla S, Kumar R, Prajapati A, Rawat N, Kumar A, Pol SL, Pol SL. Ethano-pharmacology activity & Antioxidant activity of Centella asiatica Plant Parts. NEUROQUANTOLOGY. 2022 Oct;20(11):7562-2.

Kumar R, Singh A, Painuly N. INVESTIGATION OF IN-VITRO ANTI-OXIDANT & ANTI-ULCER ACTIVITY OF POLYHERBAL MEDICINAL PLANTS. Journal of Pharmaceutical Negative Results. 2022 Oct 5:2077-88.

Larson E. Community factors in the development of antibiotic resistance. Annu. Rev. Public Health. 2007;28:435–447. doi: 10.1146/annurev.publhealth.28.021406.144020.

Wolin K.Y., Yan Y., Colditz G.A., Lee I.M. Physical activity and colon cancer prevention: A meta-analysis. Br. J. Cancer. 2009;100:611–616. doi: 10.1038/sj.bjc.6604917.

Fedirko V., Tramacere I., Bagnardi V., Rota M., Scotti L., Islami F., Negri E., Straif K., Romieu I., La Vecchia C., et al. Alcohol drinking and colorectal cancer risk: An overall and dose-response meta-analysis of published studies. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2011;22:1958–1972. doi: 10.1093/annonc/mdq653.

Lin T.C., Chien W.C., Hu J.M., Tzeng N.S., Chung C.H., Pu T.W., Hsiao C.W., Chen C.Y. Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study. PLoS ONE. 2020;15:e0232740. doi: 10.1371/journal.pone.0232740.

Pedersen A., Johansen C., Gronbaek M. Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut. 2003;52:861–867. doi: 10.1136/gut.52.6.861.

Rossi M., Anwar M.J., Usman A., Keshavarzian A., Bishehsari F. Colorectal Cancer and Alcohol Consumption-Populations to Molecules. Cancers. 2018;10:38. doi: 10.3390/cancers10020038.

Gram I.T., Park S.Y., Wilkens L.R., Haiman C.A., Le Marchand L. Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex. Am. J. Epidemiol. 2020;189:543–553. doi: 10.1093/aje/kwaa005.

Jensen K., Afroze S., Munshi M.K., Guerrier M., Glaser S.S. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. Transl. Gastrointest. Cancer. 2012;1:81–87. doi: 10.3978/j.issn.2224-4778.2011.12.01.

Aykan N.F. Red Meat and Colorectal Cancer. Oncol. Rev. 2015;9:288. doi: 10.4081/oncol.2015.288.

Bradbury K.E., Murphy N., Key T.J. Diet and colorectal cancer in UK Biobank: A prospective study. Int. J. Epidemiol. 2020;49:246–258. doi: 10.1093/ije/dyz064.

Garland C.F., Gorham E.D. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis. J. Steroid Biochem. Mol. Biol. 2017;168:1–8. doi: 10.1016/j.jsbmb.2016.12.003.

Ishihara J., Inoue M., Iwasaki M., Sasazuki S., Tsugane S. Dietary calcium, vitamin D, and the risk of colorectal cancer. Am. J. Clin. Nutr. 2008;88:1576–1583. doi: 10.3945/ajcn.2008.26195.

Valles X., Alonso M.H., Lopez-Caleya J.F., Diez-Obrero V., Dierssen-Sotos T., Lope V., Molina-Barcelo A., Chirlaque M.D., Jimenez-Moleon J.J., Tardon G.F., et al. Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study. Environ. Int. 2018;121:428–434. doi: 10.1016/j.envint.2018.09.030.

Teixeira M.C., Braghiroli M.I., Sabbaga J., Hoff P.M. Primary prevention of colorectal cancer: Myth or reality? World J. Gastroenterol. 2014;20:15060–15069. doi: 10.3748/wjg.v20.i41.15060.

Ji J., Sundquist J., Sundquist K. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden. Int. J. Cancer. 2018;142:2003–2010. doi: 10.1002/ijc.31228.

Botteri E., Stoer N.C., Sakshaug S., Graff-Iversen S., Vangen S., Hofvind S., de Lange T., Bagnardi V., Ursin G., Weiderpass E. Menopausal hormone therapy and colorectal cancer: A linkage between nationwide registries in Norway. BMJ Open. 2017;7:e017639. doi: 10.1136/bmjopen-2017-017639.

Wong S.H., Yu J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 2019;16:690–704. doi: 10.1038/s41575-019-0209-8.

Leeming E.R., Johnson A.J., Spector T.D., Le Roy C.I. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients. 2019;11:2862. doi: 10.3390/nu11122862.

Cronin K.A., Krebs-Smith S.M., Feuer E.J., Troiano R.P., Ballard-Barbash R. Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States) Cancer Causes Control. 2001;12:305–316. doi: 10.1023/A:1011244700531.

Botteri E., Iodice S., Bagnardi V., Raimondi S., Lowenfels A.B., Maisonneuve P. Smoking and colorectal cancer: A meta-analysis. JAMA. 2008;300:2765–2778. doi: 10.1001/jama.2008.839.

Bagnardi V., Rota M., Botteri E., Tramacere I., Islami F., Fedirko V., Scotti L., Jenab M., Turati F., Pasquali E. Alcohol consumption and site-specific cancer risk: A comprehensive dose–response meta-analysis. Br. J. Cancer. 2015;112:580–593. doi: 10.1038/bjc.2014.579.

Freisling H., Arnold M., Soerjomataram I., O’Doherty M.G., Ordonez-Mena J.M., Bamia C., Kampman E., Leitzmann M., Romieu I., Kee F., et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: Meta-analysis of individual participant data of seven prospective cohorts in Europe. Br. J. Cancer. 2017;116:1486–1497. doi: 10.1038/bjc.2017.106.

Vieira A.R., Abar L., Chan D.S.M., Vingeliene S., Polemiti E., Stevens C., Greenwood D., Norat T. Foods and beverages and colorectal cancer risk: A systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2017;28:1788–1802. doi: 10.1093/annonc/mdx171.

Boyle T., Keegel T., Bull F., Heyworth J., Fritschi L. Physical activity and risks of proximal and distal colon cancers: A systematic review and meta-analysis. J. Natl. Cancer Inst. 2012;104:1548–1561. doi: 10.1093/jnci/djs354.

Cao Y., Nishihara R., Wu K., Wang M., Ogino S., Willett W.C., Spiegelman D., Fuchs C.S., Giovannucci E.L., Chan A.T. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2016;2:762–769. doi: 10.1001/jamaoncol.2015.6396.

Algra A.M., Rothwell P.M. Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13:518–527. doi: 10.1016/S1470-2045(12)70112-2.